According to our (Global Info Research) latest study, the global Dermal Fillers and Botulinum Toxin market size was valued at USD 13460 million in 2022 and is forecast to a readjusted size of USD 26020 million by 2029 with a CAGR of 9.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately. Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. This report is a detailed and comprehensive analysis for global Dermal Fillers and Botulinum Toxin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Dermal Fillers and Botulinum Toxin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Dermal Fillers and Botulinum Toxin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Dermal Fillers and Botulinum Toxin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global Dermal Fillers and Botulinum Toxin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Dermal Fillers and Botulinum Toxin To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Dermal Fillers and Botulinum Toxin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz and Medytox, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Dermal Fillers and Botulinum Toxin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Dermal Fillers Botulinum Toxin Market segment by Application Cosmetic Medical Major players covered AbbVie Galderma LG Life Sciences Merz Medytox Hugel Croma-Pharma Beijing IMEIK Bloomage Bio Elravie (Humedix) Cleviel (Pharma Research Products) Haohai Biological Teoxane Sinclair Suneva Medical CG Bio SciVision Biotech Prollenium Bohus BioTech Caregen Ipsen LIBP US World Meds Daewoong JETEMA Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Dermal Fillers and Botulinum Toxin product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Dermal Fillers and Botulinum Toxin, with price, sales, revenue and global market share of Dermal Fillers and Botulinum Toxin from 2018 to 2023. Chapter 3, the Dermal Fillers and Botulinum Toxin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Dermal Fillers and Botulinum Toxin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Dermal Fillers and Botulinum Toxin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Dermal Fillers and Botulinum Toxin. Chapter 14 and 15, to describe Dermal Fillers and Botulinum Toxin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Dermal Fillers and Botulinum Toxin Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Dermal Fillers 1.3.3 Botulinum Toxin 1.4 Market Analysis by Application 1
